Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolism and Disposition of [14C] Hetrombopag in Healthy Chinese Men
NCT03977805Phase 1Completed
- Sponsor
- Hengrui
- Start
- May 2019
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of hetrombopag in Thrombocytopenia, sponsored by Hengrui. Primary endpoints: Total radioactivity pharmacokinetics in whole blood and plasma, Total radioactivity in the excreta and 2 more. Started May 2019; status: completed.
02
Drugs
hetrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT03977805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03977805.